SOP

Innoviz Reiterates Value Proposition in Open Letter to Shareholders

Retrieved on: 
Wednesday, August 16, 2023

TEL AVIV, Israel, Aug. 16, 2023 /PRNewswire/ -- Innoviz Technologies Ltd. (NASDAQ: INVZ) ("Innoviz"), a leading Tier-1 direct supplier of high-performance, automotive grade LiDAR sensors and perception software, today issued an open letter to its shareholders following its recently-completed underwritten public offering of ordinary shares, in which Co-Founder and CEO Omer Keilaf highlights the Company's strong operational execution and recent customer wins.

Key Points: 
  • Innoviz is currently participating in over five active RFQ sourcing processes, all with major automotive OEMs.
  • We believe we are in a once-in-a-lifetime market share capture window for the automotive LiDAR industry.
  • Winner Takes Most Market: At Innoviz, we believe the automotive LiDAR industry is ultimately going to be a winner-takes-most market.
  • When combined, these factors point to a strong backdrop for Innoviz in the programs that we are actively competing on.

Luminar Reports Strong Second Quarter 2023 Business Update and Financials

Retrieved on: 
Tuesday, August 8, 2023

Today Luminar (NASDAQ: LAZR), a leading global automotive technology company, provided its quarterly business update and financial results for the second quarter of 2023.

Key Points: 
  • Today Luminar (NASDAQ: LAZR), a leading global automotive technology company, provided its quarterly business update and financial results for the second quarter of 2023.
  • In Q2, Luminar also announced a partnership with TPK to build and operate an additional high volume factory in Asia.
  • Cash, Cash Equivalents and Marketable Securities: Maintained strong cash position, including marketable securities, of $365.8 million as of June 30, 2023.
  • What: Video webcast featuring quarterly business update, Q2 financials and live Q&A
    A live webcast of the event will be available on Luminar’s investor site at https://luminartech.com/quarterlyreview .

China Autonomous Driving Domain Controller Research Report 2023: Advancements Towards L2++ and L2+++ Mass Production - ResearchAndMarkets.com

Retrieved on: 
Monday, August 7, 2023

The "China Autonomous Driving Domain Controller Research Report, 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "China Autonomous Driving Domain Controller Research Report, 2023" report has been added to ResearchAndMarkets.com's offering.
  • Autonomous driving domain controller research: explore computing power distribution and evolution strategies for driving-parking integrated domain controllers.
  • In China, at this stage the industry is concentrating efforts on mass production and application of L2++ or L2+++ autonomous driving that is infinitely close to L3.
  • The autonomous driving development path is becoming clear, and the industry heads in the direction of "cost reduction" and "efficiency improvement".

The Future of Potency Testing: Orange Photonics Revolutionizes HPLC Science with Portable, Edibles-Capable Cannabis Analyzer for Non-Technical Users

Retrieved on: 
Friday, August 4, 2023

Orange Photonics, a leader in portable HPLC science, reports on the impact of LightLab 3 HS Cannabis Analyzer.

Key Points: 
  • Orange Photonics, a leader in portable HPLC science, reports on the impact of LightLab 3 HS Cannabis Analyzer.
  • Prior to LightLab 3 HS, analysis of low dose cannabis products was not possible in non-laboratory environments.
  • Non-technical users can now perform rapid and cost-effective in-house potency testing on cannabis plants and concentrates, as well as all types of cannabis-infused edibles and beverages.
  • Over the last nine months, we have witnessed the beginning of transformation in the way potency testing is conducted across the industry."

Beverly Hills Fertility (BHF) Pioneers Personalized Cryopreservation Protocols to Revolutionize Fertility Industry

Retrieved on: 
Thursday, August 3, 2023

Dr. Liu, BHF's skilled IVF lab director, stands out for his unwavering commitment to personalized protocols, setting BHF apart from other reproductive clinics.

Key Points: 
  • Dr. Liu, BHF's skilled IVF lab director, stands out for his unwavering commitment to personalized protocols, setting BHF apart from other reproductive clinics.
  • Embracing the concept of customized cryopreservation protocols in the era of personalized medicine can significantly enhance success rates.
  • Beverly Hills Fertility (BHF) recognizes the potential of AI applications in IVF clinics to enhance personalized approaches, which has already been proven successful at BHF.
  • Looking ahead, the future of cryopreservation appears promising, envisioning a world where personalized medicine becomes the norm.

Strategic Intellectual Property Acquisition Fuels Blinc's Cannabis Vaping Innovation

Retrieved on: 
Wednesday, August 2, 2023

New York, NY, Aug. 02, 2023 (GLOBE NEWSWIRE) -- The Blinc Group, a leader in cannabis vaping solutions, announced today the acquisition of an international, highly innovative patent portfolio from Bergstrom Innovations, furthering its commitment to delivering safer, more effective, and superior vaping experiences for the global cannabis community.

Key Points: 
  • New York, NY, Aug. 02, 2023 (GLOBE NEWSWIRE) -- The Blinc Group, a leader in cannabis vaping solutions, announced today the acquisition of an international, highly innovative patent portfolio from Bergstrom Innovations, furthering its commitment to delivering safer, more effective, and superior vaping experiences for the global cannabis community.
  • "These new patents serve to bolster our 'Powered by Blinc' process" said Arnaud Dumas de Rauly, CEO of The Blinc Group.
  • "Our ambition has always been to empower our clients to deliver innovative, safe, and quality-controlled products to consumers around the world.
  • While specifics of the patent portfolio acquisition are confidential, the acquired technology underscores The Blinc Group's dedication to fostering clients' growth through continuous innovation and technological enhancement.

ProPharma Announces the Appointment of Helen Hall as Global Head of Clinical Data Sciences

Retrieved on: 
Wednesday, August 2, 2023

RALEIGH, N.C., Aug. 2, 2023 /PRNewswire-PRWeb/ -- ProPharma Group (ProPharma), the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, and a portfolio company of Odyssey Investment Partners, today announced the appointment of Helen Hall as Global Head of Clinical Data Sciences, where she will lead clinical data management, as well as biostatistics and programming.

Key Points: 
  • RALEIGH, N.C., Aug. 2, 2023 /PRNewswire-PRWeb/ -- ProPharma Group (ProPharma), the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, and a portfolio company of Odyssey Investment Partners, today announced the appointment of Helen Hall as Global Head of Clinical Data Sciences, where she will lead clinical data management, as well as biostatistics and programming.
  • Prior to joining ProPharma, the world's largest RCO (Research Consulting Organization), Hall served in several senior leadership capacities at Syneos Health (Synteract), most recently as Senior Vice President, Clinical Data Sciences and Biometrics.
  • Upon her appointment, Hall shared, "I am thrilled to join ProPharma and leverage my experience in clinical research, data sciences, and biometrics to propel the company's strategic objectives.
  • ProPharma's steadfast commitment to innovation and the ongoing advancement of its revolutionary Research Consulting Organization (RCO) model is reaffirmed with the appointment of Hall as the Global Head of Clinical Data Sciences.

PetIQ, Inc. Appoints John Pearson to Executive Vice President, Services & Manufactured Products

Retrieved on: 
Wednesday, August 2, 2023

EAGLE, Idaho, Aug. 02, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that John Pearson, who has served as the Company’s Senior Vice President, Head of Services since 2022, has been appointed Executive Vice President, Services & Manufactured Products, a newly created role, effective August 2, 2023.

Key Points: 
  • EAGLE, Idaho, Aug. 02, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that John Pearson, who has served as the Company’s Senior Vice President, Head of Services since 2022, has been appointed Executive Vice President, Services & Manufactured Products, a newly created role, effective August 2, 2023.
  • In his new role, Pearson will gain responsibility for PetIQ’s manufactured product portfolio, inclusive of the Company’s sales and marketing teams, while maintaining his current responsibilities for the Services segment.
  • Pearson will continue to report directly to Michael Smith, President and Chief Operating Officer.
  • Prior to joining PetIQ, Pearson served as President and Chief Executive Officer of Good2Go Stores, a multi-state convenience store chain from March 2020 to May 2022.

Innoviz Reports Second-Quarter 2023 Results and Increases 2023 Financial Targets Following Continued Commercial Momentum

Retrieved on: 
Wednesday, August 2, 2023

TEL AVIV, Israel , Aug. 2, 2023 /PRNewswire/ -- Innoviz Technologies Ltd. (Nasdaq: INVZ) (the "Company" or "Innoviz"), a leading Tier-1 direct supplier of high-performance, automotive grade LiDAR sensors and perception software, today provided commercial and strategic updates on its business, reported its financial results for the second quarter ended June 30, 2023 and raised 2023 financial targets.

Key Points: 
  • Innoviz's second SOP launch for 2023 with its shuttle program also continues to make progress, with production shipments planned for the coming months.
  • Innoviz is developing the solution as a Tier-1 supplier and is targeting late 2023 or early 2024.
  • - Began shipping units to new light commercial vehicle program – Innoviz previously announced a new light commercial vehicle program customer in conjunction with the first quarter 2023 earnings announcement.
  • Innoviz management will hold a web conference today, August 2, 2023, at 9:00 a.m. Eastern time (6:00 a.m. Pacific time) to discuss commercial and strategic updates, financial results for the second quarter ended June 30, 2023 and 2023 financial targets.

Biden-Harris Administration Launches Small Business Loan Program Improvements to Expand Access to Capital Starting today, August 1

Retrieved on: 
Tuesday, August 1, 2023

WASHINGTON, Aug. 01, 2023 (GLOBE NEWSWIRE) -- On August 1, the U.S. Small Business Administration (SBA) began implementing additional policies aimed at expanding small business access to capital by modernizing SBA’s signature 7(a) and 504 Loan Programs.

Key Points: 
  • WASHINGTON, Aug. 01, 2023 (GLOBE NEWSWIRE) -- On August 1, the U.S. Small Business Administration (SBA) began implementing additional policies aimed at expanding small business access to capital by modernizing SBA’s signature 7(a) and 504 Loan Programs.
  • Today’s loan program updates build on Administrator Isabella Casillas Guzman’s previous announcements that address long-standing persistent capital access gaps for rural, veteran, women, and minority-owned businesses.
  • The loan program improvements will increase small businesses’ ability to access funding to start up and grow through a broader network of lenders with streamlined lender procedures.
  • These lenders are securing permanency in the 7(a) Loan Program by becoming Community Advantage Small Business Lending Companies (CASBLCs).